290 related articles for article (PubMed ID: 20964730)
1. Nigral and striatal regulation of angiotensin receptor expression by dopamine and angiotensin in rodents: implications for progression of Parkinson's disease.
Villar-Cheda B; Rodríguez-Pallares J; Valenzuela R; Muñoz A; Guerra MJ; Baltatu OC; Labandeira-Garcia JL
Eur J Neurosci; 2010 Nov; 32(10):1695-706. PubMed ID: 20964730
[TBL] [Abstract][Full Text] [Related]
2. Aging-related dysregulation of dopamine and angiotensin receptor interaction.
Villar-Cheda B; Dominguez-Meijide A; Valenzuela R; Granado N; Moratalla R; Labandeira-Garcia JL
Neurobiol Aging; 2014 Jul; 35(7):1726-38. PubMed ID: 24529758
[TBL] [Abstract][Full Text] [Related]
3. Aging-related changes in the nigral angiotensin system enhances proinflammatory and pro-oxidative markers and 6-OHDA-induced dopaminergic degeneration.
Villar-Cheda B; Valenzuela R; Rodriguez-Perez AI; Guerra MJ; Labandeira-Garcia JL
Neurobiol Aging; 2012 Jan; 33(1):204.e1-11. PubMed ID: 20888078
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin AT
Rivas-Santisteban R; Rodriguez-Perez AI; Muñoz A; Reyes-Resina I; Labandeira-García JL; Navarro G; Franco R
J Neuroinflammation; 2020 Aug; 17(1):243. PubMed ID: 32807174
[TBL] [Abstract][Full Text] [Related]
5. Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS.
Rodriguez-Pallares J; Rey P; Parga JA; Muñoz A; Guerra MJ; Labandeira-Garcia JL
Neurobiol Dis; 2008 Jul; 31(1):58-73. PubMed ID: 18499466
[TBL] [Abstract][Full Text] [Related]
6. Effect of chronic treatment with angiotensin type 1 receptor antagonists on striatal dopamine levels in normal rats and in a rat model of Parkinson's disease treated with L-DOPA.
Dominguez-Meijide A; Villar-Cheda B; Garrido-Gil P; Sierrra-Paredes G; Guerra MJ; Labandeira-Garcia JL
Neuropharmacology; 2014 Jan; 76 Pt A():156-68. PubMed ID: 23973568
[TBL] [Abstract][Full Text] [Related]
7. Involvement of microglial RhoA/Rho-kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors.
Villar-Cheda B; Dominguez-Meijide A; Joglar B; Rodriguez-Perez AI; Guerra MJ; Labandeira-Garcia JL
Neurobiol Dis; 2012 Aug; 47(2):268-79. PubMed ID: 22542954
[TBL] [Abstract][Full Text] [Related]
8. Reciprocal regulation between sirtuin-1 and angiotensin-II in the substantia nigra: implications for aging and neurodegeneration.
Diaz-Ruiz C; Rodriguez-Perez AI; Beiroa D; Rodriguez-Pallares J; Labandeira-Garcia JL
Oncotarget; 2015 Sep; 6(29):26675-89. PubMed ID: 26384348
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II receptor binding associated with nigrostriatal dopaminergic neurons in human basal ganglia.
Allen AM; MacGregor DP; Chai SY; Donnan GA; Kaczmarczyk S; Richardson K; Kalnins R; Ireton J; Mendelsohn FA
Ann Neurol; 1992 Sep; 32(3):339-44. PubMed ID: 1416803
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin type 2 receptors: Role in aging and neuroinflammation in the substantia nigra.
Rodriguez-Perez AI; Garrido-Gil P; Pedrosa MA; Garcia-Garrote M; Valenzuela R; Navarro G; Franco R; Labandeira-Garcia JL
Brain Behav Immun; 2020 Jul; 87():256-271. PubMed ID: 31863823
[TBL] [Abstract][Full Text] [Related]
11. Estrogen upregulates renal angiotensin II AT1 and AT2 receptors in the rat.
Baiardi G; Macova M; Armando I; Ando H; Tyurmin D; Saavedra JM
Regul Pept; 2005 Jan; 124(1-3):7-17. PubMed ID: 15544836
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration.
Valenzuela R; Costa-Besada MA; Iglesias-Gonzalez J; Perez-Costas E; Villar-Cheda B; Garrido-Gil P; Melendez-Ferro M; Soto-Otero R; Lanciego JL; Henrion D; Franco R; Labandeira-Garcia JL
Cell Death Dis; 2016 Oct; 7(10):e2427. PubMed ID: 27763643
[TBL] [Abstract][Full Text] [Related]
13. Expression of angiotensin II type 1 (AT1) and angiotensin II type 2 (AT2) receptors in human granulosa-lutein (GL) cells: correlation with infertility diagnoses.
Peña O; Palumbo A; González-Fernández R; Hernández J; Naftolin F; Avila J
Fertil Steril; 2010 Mar; 93(5):1601-8. PubMed ID: 19524223
[TBL] [Abstract][Full Text] [Related]
14. Type 1 angiotensin receptor (AT1-R)-mediated decrease in type 2 angiotensin receptor mRNA level is dependent on Gq and extracellular signal-regulated kinase 1//2 in AT1-R-transfected PC12 cells.
Saito M; Shinohara Y; Sasaki H; Netsu Y; Yoshida M; Nakahata N
J Neuroendocrinol; 2008 Mar; 20(3):299-308. PubMed ID: 18208547
[TBL] [Abstract][Full Text] [Related]
15. The inflammatory response in the MPTP model of Parkinson's disease is mediated by brain angiotensin: relevance to progression of the disease.
Joglar B; Rodriguez-Pallares J; Rodriguez-Perez AI; Rey P; Guerra MJ; Labandeira-Garcia JL
J Neurochem; 2009 Apr; 109(2):656-69. PubMed ID: 19245663
[TBL] [Abstract][Full Text] [Related]
16. Denervation and repeated L-DOPA induce complex regulatory changes in neurochemical phenotypes of striatal neurons: implication of a dopamine D1-dependent mechanism.
St-Hilaire M; Landry E; Lévesque D; Rouillard C
Neurobiol Dis; 2005 Nov; 20(2):450-60. PubMed ID: 15896973
[TBL] [Abstract][Full Text] [Related]
17. Interaction between NADPH-oxidase and Rho-kinase in angiotensin II-induced microglial activation.
Rodriguez-Perez AI; Borrajo A; Rodriguez-Pallares J; Guerra MJ; Labandeira-Garcia JL
Glia; 2015 Mar; 63(3):466-82. PubMed ID: 25377425
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin AT2 receptor stimulation inhibits activation of NADPH oxidase and ameliorates oxidative stress in rotenone model of Parkinson's disease in CATH.a cells.
Lu J; Wu L; Jiang T; Wang Y; Zhao H; Gao Q; Pan Y; Tian Y; Zhang Y
Neurotoxicol Teratol; 2015; 47():16-24. PubMed ID: 25446015
[TBL] [Abstract][Full Text] [Related]
19. Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects.
Masaki H; Kurihara T; Yamaki A; Inomata N; Nozawa Y; Mori Y; Murasawa S; Kizima K; Maruyama K; Horiuchi M; Dzau VJ; Takahashi H; Iwasaka T; Inada M; Matsubara H
J Clin Invest; 1998 Feb; 101(3):527-35. PubMed ID: 9449684
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease.
Calabresi P; Mercuri NB; Sancesario G; Bernardi G
Brain; 1993 Apr; 116 ( Pt 2)():433-52. PubMed ID: 8096420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
